BRIDGEBIO PHARMA INC

BBIO · NASDAQ

Updated at 2026-10-13 14:11:10

$64.58-1.77%
Today's High
$66.07
Today’s Low
$64.30
BRIDGEBIO PHARMA INC (BBIO) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$65.35
Previous Close
$65.75
Volume
1.77M
Market Cap
$12.85B
P/E Ratio
--
EPS
$-3.56

Previous Day Range

$65.20$66.41

52-Week Range

$52.75$93.41

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
3160 PORTER DRIVE, PALO ALTO, CA, UNITED STATES, 94304
Country
US
Listing Date
2019-06-27
Fiscal Year End
December
Shares Outstanding
195.86M
CIK
0001743881

BridgeBio Pharma, Inc. is dedicated to the discovery, development and supply of various drugs for genetic diseases. The company is headquartered in Palo Alto, California.

Financial Metrics

Revenue

2026-06-30

$243.67M

2026-03-31

$194.51M

2025-12-31

$154.18M

2025-09-30

$120.7M

Operating Expenses

2026-06-30

$335.7M

2026-03-31

$290.04M

2025-12-31

$324M

2025-09-30

$259.33M

Net Income

2026-06-30

-$152.21M

2026-03-31

-$164.04M

2025-12-31

-$197.23M

2025-09-30

-$182.74M

Net Profit Margin

2026-06-30

-62.46%

2026-03-31

-84.33%

2025-12-31

-127.92%

2025-09-30

-151.4%

Earnings Per Share

2026-06-30

$-0.78

2026-03-31

$-0.84

2025-12-31

$-0.93

2025-09-30

$-0.72

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$141.56M

2026-03-31

-$112.55M

2025-12-31

-$183.8M

2025-09-30

-$173.34M

Effective Tax Rate

2026-06-30

3.96%

2026-03-31

--

2025-12-31

--

2025-09-30

0.82%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.